INTRODUCTION: HIV Pre-Exposure Prophylaxis (PrEP) consists of administering antiretroviral drugs to seronegative individuals with high risk practices. The aim of the study was to describe the characteristics of recent seroconverted HIV patients in order to determine the profile of the appropriate candidates for PrEP. METHODS: A descriptive study of all patients diagnosed with HIV infection in 2014, and who had achieved a documented negative serology over the previous 12 months. A specific form was completed to determine the sociodemographic, behavioural, and clinical features, with complementary tests being performed for other sexually transmitted infections. RESULTS: Almost all (98.4%) of the 61 recent seroconverted were men who have sex with men, and aged between 20 to 39 years (88.5%). They also had a background of sexually transmitted infections (80.3%), performed multiple and unprotected sexual practices (82.7%), and under the effect of recreational drugs (87%). CONCLUSIONS: The evaluation of the risk factors for HIV infection in seronegative patients should enable the appropriate candidates for PrEP to be identified.
INTRODUCTION: HIV Pre-Exposure Prophylaxis (PrEP) consists of administering antiretroviral drugs to seronegative individuals with high risk practices. The aim of the study was to describe the characteristics of recent seroconverted HIV patients in order to determine the profile of the appropriate candidates for PrEP. METHODS: A descriptive study of all patients diagnosed with HIV infection in 2014, and who had achieved a documented negative serology over the previous 12 months. A specific form was completed to determine the sociodemographic, behavioural, and clinical features, with complementary tests being performed for other sexually transmitted infections. RESULTS: Almost all (98.4%) of the 61 recent seroconverted were men who have sex with men, and aged between 20 to 39 years (88.5%). They also had a background of sexually transmitted infections (80.3%), performed multiple and unprotected sexual practices (82.7%), and under the effect of recreational drugs (87%). CONCLUSIONS: The evaluation of the risk factors for HIV infection in seronegative patients should enable the appropriate candidates for PrEP to be identified.
Keywords:
Human immunodeficiency virus; Pre-exposure prophylaxis; Profilaxis pre-exposición; Recent seroconvertor; Seroconvertores recientes; Virus de la inmunodeficiencia humana
Authors: E E Lozano Rincón; C Rodríguez Martín; O Ayerdi Aguirrebengoa; M Vera García; R Serrano Heranz; J Del Romero Guerrero Journal: Rev Esp Quimioter Date: 2019-09-26 Impact factor: 1.553
Authors: E Bouza; J R Arribas; B Alejos; J I Bernardino; M Coiras; P Coll; J Del Romero; M J Fuster; M Górgolas; A Gutiérrez; D Gracia; V Hernando; J Martínez-Picado; J M Martínez Sesmero; E Martínez; S Moreno; B Mothe; M L Navarro; D Podzamczer; F Pulido; J T Ramos; E Ruiz-Mateos; I Suárez García; E Palomo Journal: Rev Esp Quimioter Date: 2022-01-12 Impact factor: 1.553
Authors: Carlos Iniesta; Débora Álvarez-Del Arco; Luis Miguel García-Sousa; Belén Alejos; Asunción Díaz; Nieves Sanz; Jorge Garrido; Michael Meulbroek; Ferran Pujol; Santiago Moreno; María José Fuster-Ruiz de Apocada; Pep Coll; Antonio Antela; Jorge Del Romero; Oskar Ayerdi; Melchor Riera; Juanse Hernández; Julia Del Amo Journal: PLoS One Date: 2018-10-19 Impact factor: 3.240
Authors: Guillermo López-Díaz; Almudena Rodríguez-Fernández; Eva María Domínguez-Martís; Diego Gabriel Mosteiro-Miguéns; David López-Ares; Silvia Novío Journal: Int J Environ Res Public Health Date: 2020-09-29 Impact factor: 3.390